Limpopo Clinical Research Initiative
Thabazimbi, Limpopo, South Africa
Disclosure(s): No financial relationships to disclose
92 - Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial
Thursday, October 17, 2024
11:30 AM – 11:43 AM US PT